C

Celldex Therapeutics
D

CLDX

23.360
USD
0.11
(0.47%)
مغلق
حجم التداول
49,047
الربح لكل سهم
-3
العائد الربحي
-
P/E
-9
حجم السوق
1,550,969,470
أصول ذات صلة
A
ARVN
-0.05000
(-0.63%)
7.84500 USD
C
CRVS
-0.05500
(-1.16%)
4.70000 USD
F
FATE
-0.01000
(-0.80%)
1.23500 USD
MRNA
MRNA
0.125
(0.37%)
34.145 USD
N
NKTR
0.420
(1.71%)
25.020 USD
T
TGTX
0.420
(1.15%)
36.900 USD
المزيد
الأخبار المقالات

العنوان: Celldex Therapeutics

القطاع: Healthcare
الصناعة: Biotechnology
Celldex Therapeutics Inc is a biopharmaceutical company. It is focused on the development and commercialization of several immunotherapy technologies and other cancer-targeting biologics. The company is also engaged in clinical trials for products targeting breast cancer, metastatic melanoma, lung cancer, solid tumors, and ovarian cancer. It has single operating and reportable segment that operates in the business of development, manufacturing and commercialization of novel therapeutics for human health care.